Sign in Create account

Colinz Laboratories ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 531210
₹76.69
Sept. 30, 2026 · BSE · bse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #164 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

CompanyMarket cap (₹ Cr)PE (TTM)ROE1Y returnDiv. yieldQualityValuationMomentum
Sun Pharmaceutical Industries Limited 435,863 146.5 13.7% 11.0% — 72 8 30
Divi's Laboratories Limited 246,660 83.9 15.3% 62.7% 0.32% 70 4 51
Torrent Pharmaceuticals Limited 162,454 78.2 12.2% 34.6% 0.79% 56 0 31
Zydus Lifesciences Limited 115,910 33.3 17.3% 17.2% 0.09% 74 24 84
Cipla Limited 108,736 35.4 11.2% -11.0% 0.97% 73 29 62
Laurus Labs Limited 106,969 122.5 17.1% 127.1% — 78 24 53
Mankind Pharma Limited 103,406 47.4 11.7% 2.6% — 68 12 86
Dr. Reddy's Laboratories Limited 102,916 154.7 10.9% -0.9% — 62 33 71
Colinz Laboratories ltd. (this stock) 19 6.9 4.8% 7.1% — 69 94 52

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value
₹19 Cr
EV / EBITDA
5.2x
EV / Sales
3.27x
Market cap / Sales
3.32x
Earnings yield
14.47%

Quarterly Financials

Download CSV
Standalone Consolidated
↓ Negative
Quarterly Revenue

Jun 2026 quarterly revenue is Rs 1 Cr, down 16.9% YoY.

↑ Positive
Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 2 Cr, up 1917.6% YoY.

Period endRevenue (₹ Cr)PBT (₹ Cr)Net profit (₹ Cr)Basic EPS
June 30, 2026 1 3 2 ₹9.5300
March 31, 2026 2 0 0 ₹0.6800
Dec. 31, 2025 1 0 — ₹0.3300
Sept. 30, 2025 1 0 0 ₹0.5600
June 30, 2025 2 0 0 ₹0.5400
March 31, 2025 1 0 — ₹0.6000
Dec. 31, 2024 1 0 0 ₹0.2100
Sept. 30, 2024 2 0 0 ₹0.6200
June 30, 2024 2 0 0 ₹0.5400
March 31, 2024 2 0 0 ₹0.5400
Dec. 31, 2023 2 0 0 ₹0.4200
Sept. 30, 2023 2 0 0 ₹0.4900
June 30, 2023 2 0 0 ₹0.4800

Quarterly income statement (standalone, ₹ Cr)

IndicatorJun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23
Total income (before exceptional items)1222222222222
Operating revenue1211211222222
Other income0000000000000
Operating expenses1211111222222
Operating profit0000000000000
Operating profit margin5.0%5.2%7.1%5.7%8.7%6.7%4.3%9.3%9.1%7.6%8.3%7.1%7.9%
Depreciation0000000000000
Interest0000000000000
Exceptional items, gain / (loss)3————————————
Profit before tax3000000000000
Tax00000-00000000
Net profit20—00—0000000
EPS9.530.680.330.560.540.600.210.620.540.540.420.490.48
Net profit (TTM)——————0110000
EPS (TTM)11.102.112.031.911.971.971.912.121.991.931.901.891.86

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

IndicatorCAGR 3YCAGR 5YMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Total income (before exceptional items) -3.3% 0.8% 7†7†7†7†7†6†8†8†8†8†
Operating revenue -5.0% -0.1% 6†7†7†7†7†6†8†8†8†8†
Other income — — 0†0†0†0†0†0†0†0†0†0†
Operating expenses — — 6†6†6†7†6†6†7†7†—7†
Operating profit -12.6% 4.1% 0†0†1†1†1†0†0†0†—0†
Operating profit margin — — 6.6%†7.6%†7.7%†8.5%†8.4%†5.4%†4.0%†4.6%†—6.4%†
Depreciation — — 0†0†0†0†0†0†0†0†—0†
Interest — — 0†0†0†0†0†0†0†0†0†0†
Exceptional items, gain / (loss) — — 0†0†0†0†0†0†0†0†0†0†
Profit before tax 4.7% 23.0% 1†1†1†1†0†0†0†0†0†0†
Tax — — 0†0†0†0†0†—0†0†—0†
Net profit — — ——0†0†0†0†0†0†0†0†
EPS 5.1% 15.9% 2.11†1.97†1.93†1.82†0.93†1.01†————

† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

RatioMar 26Mar 25Mar 24Mar 23Mar 22Mar 21Mar 20Mar 19Mar 18Mar 17
Operating margin6.6%†7.6%†7.7%†8.5%†8.4%†5.4%†4.0%†4.6%†—6.4%†
EBIT margin12.0%†10.1%†9.8%†9.1%†8.0%†5.4%†3.2%†3.3%†2.9%†3.7%†
PBT margin11.2%†9.5%†9.3%†8.4%†6.9%†4.0%†2.3%†2.0%†1.9%†2.2%†
Net margin——6.9%†6.4%†4.9%†3.4%†1.7%†1.6%†2.9%†1.9%†
Interest coverage15.84x†15.60x†18.50x†12.49x†7.37x†3.83x†3.63x†2.60x†2.79x†2.43x†
Dividend payout——————————
Earnings retention——————————
Current ratio3.68x4.17x————————
Quick ratio3.42x3.81x————————
Debt to equity0.04x0.07x————————
Return on equity——————————
Return on assets——————————
Return on capital employed7.3%†6.9%†————————
Asset turnover0.48x†0.55x†————————

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year endedOperating (₹ Cr)Investing (₹ Cr)Financing (₹ Cr)Capex (₹ Cr)Free Cash Flow (₹ Cr)
March 31, 2026 3 0 -0 0 3
March 31, 2025 -1 0 -0 0 -2

Balance Sheet (standalone)

Year endedTotal Assets (₹ Cr)Total Equity (₹ Cr)Reserves (₹ Cr)Borrowings, Current (₹ Cr)Borrowings, Non-current (₹ Cr)Current Assets (₹ Cr)Current Liabilities (₹ Cr)Cash & Equivalents (₹ Cr)Net Block (₹ Cr)Inventory (₹ Cr)
March 31, 2026 13 10 8 0 0 10 3 1 2 1
March 31, 2025 12 9 7 1 0 9 2 2 2 1

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.